[1] |
HAO Xiao, ZHAO Mei, WANG Wenjing, ZHANG Feifei, LIU Huiliang, DANG Yi, LI Shuren, QI Xiaoyong.
Application of sodium-glucose cotransporter 2 inhibitors in acute myocardial infarction
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 824-831.
|
[2] |
CHEN Yetao, HE Junyu, WU Mengyao, WAN Fangzhu, HE Haibo, TANG Hongbo.
Study on PLGA-based nanoparticles in gynecological diseases
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(4): 455-462.
|
[3] |
LI Shan, LIU Yixin, REN Feifei, LI Xiangchen, ZHANG Zhiqing.
Research progress of natural plant active ingredients in reversing tumor multidrug resistance by down-regulating P-gp
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(3): 331-340.
|
[4] |
DU Jie, ZHAO Tingting, WANG Dalong, CHEN Xiaodong, LIU Kexin, WU Jingjing.
Role and research progress of CYP46A1 in neurodegenerative diseases
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(8): 925-935.
|
[5] |
HE Xueru, FU Yuhao, XUN Xuejiao, CUI Yanjun, DONG Zhanjun.
Advances in uridine diphosphate glucuronosyltransferase-mediated drug interactions with tyrosine kinase inhibitors
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(8): 936-945.
|
[6] |
LI Miao, YU Qinwei, JIANG Zhenzhou, ZHANG Luyong, .
Regulatory mechanism of LDLR and research progress of its related diseases and drugs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(8): 946-954.
|
[7] |
PAN Shu, WU Yijin, ZHANG Sasa, WANG Qihai, LUO Tingting, YIN Qin.
Pharmacokinetics of methotrexate mediated by organic anion transporter 3 in adjuvant induced arthritis rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(5): 516-525.
|
[8] |
PENG Juan, FAN Linlin, LI Ranyi, LI Xiaoyu, LV Qianzhou, ZOU Yunzeng.
Progress of pharmacotherapy for heart failure
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(4): 373-381.
|
[9] |
CAI Zichun, JIANG Yuanzhen, ZHANG Chunsheng, LI Jiming.
Research progress and application prospects of circRNA in cardiovascular diseases
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(4): 397-404.
|
[10] |
CHEN Jiayin, WANG Li, WANG Lijun, TONG Gangling, MA Jie, CHEN Xijing, LU Yang.
Correlation between organic cation transporter gene polymorphisms and the toxicities and clinical response of oxaliplatin
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(2): 171-177.
|
[11] |
FAN Wenxiang, ZHANG JinLu, XU Chi.
Research progress of α7 nicotinic acetylcholine receptors in central nervous system diseases
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(9): 1065-1072.
|
[12] |
LIU Lu, CHEN Xiaoyan.
Current status of clinical drug-drug interactions research of innovative small molecule drugs in China
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(8): 863-875.
|
[13] |
ZHOU Han, LIU Xiaodong.
Application of physiologically based pharmacokinetic model in drug development and several questions being thought
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(8): 889-913.
|
[14] |
ZHANG Yuanjin, HUANG Shengbo, LIU Jie, WANG Xin.
Construction and application of innovation gene-edited rats and intestinal 3D organoids models in drug metabolism and pharmacokinetics
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(8): 914-922.
|
[15] |
LU Ming, YIN Xiaoyu, ZHANG Zhiqing.
Research progress and mechanism of mesenchymal stem cells in the treatment of autoimmune diseases
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(6): 700-706.
|